Task: Answer the multiple choice question.
Question: Which compound exhibits a -25.005% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CCOCCCn1cnc2c([nH]c3cc(OC)ccc32)c1=O
b. O=C(NCCc1ccccn1)c1cccc(S(=O)(=O)N2CCc3ccccc32)c1
Answer: b. O=C(NCCc1ccccn1)c1cccc(S(=O)(=O)N2CCc3ccccc32)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(NCCc1ccccn1)c1cccc(S(=O)(=O)N2CCc3ccccc32)c1
O=C(NCCc1ccccn1)c1cccc(S(=O)(=O)N2CCc3ccccc32)c1
3-(2,3-dihydroindol-1-ylsulfonyl)-N-(2-pyridin-2-ylethyl)benzamide